Session 3 - Food and drug allergies; urticaria, angioedema, anaphylaxis, mast cells, mastocytosis and mast cell activation disorders
April 22, 2022
7:30-10:15 am CST
Moderators
Donata Vercelli, MD
Deborah Meyers, PhD
Intro & Welcome
Donata Vercelli, MD
7:30-7:45 am
Temporal trends of skin prick tests for food induced allergic reactions/anaphylaxis
Pasquale Mulé
Abstract #36
7:45-8:00 am
Sensitization to seafood in Tanzanian AD patients – a dietary miracle
Claudia CV Lang
Abstract #38
8:00-8:15 am
Eosinophil, neutrophil and basophil infiltration in chronic spontaneous urticaria: relationship to basophil activation status, dermographism and severity scores
Alison Sears, MBChB (Hons) BSc MRCP UK (Derm)
Abstract #37
8:15-8:30 am
Monensin induces selective mast cell apoptosis through a secretory granule-mediated pathway
Gunnar Pejler, PhD
Abstract #25
8:30-8:45 am
Phenotypic and functional characterization of Siglec-6 on human mast cells
Bruce Bochner, MD
Abstract #5
8:45-8:55 am
BREAK
8:55-9:10 am
Critical role for Solute Carrier Proteins for mast cell function
Adrian Piliponsky
Abstract #11
9:10-9:25 am
Fluoxetine suppresses IgE-mediated mast cell function
John Ryan, PhD
Abstract #1
9:25-9:40 am
Internalization of a benzylisoquinoline alkaloid by resting and IL-3-activated mast cells utilizes energy-dependent mechanisms
Marianna Kulka, PhD
Abstract #3
9:40-9:55 am
Differential mast cell urinary mediators in systemic mastocytosis and hereditary alpha-tryptasemia
Grace Godwin, BA & Emily Weller, BA
Abstract #19
9:55-10:10 am
Neurobehavioral dimensions of depression in mastocytosis: A pilot study
Jennifer Nicoloro-SantaBarbara, PhD
Abstract #47
10:10
Closing Remarks
Deborah Meyers, PhD
|